Medicare Forces a Cruel Choice: Curative Treatment or Hospice, Not Both

Under the Medicare Hospice Benefit, patients must forgo curative treatment for their terminal illness in order to receive hospice services. A cancer patient who wants both palliative chemotherapy and hospice nursing support cannot have them simultaneously under standard Medicare. This forces patients into a binary choice that does not reflect how modern medicine works, where the line between curative and palliative intent is often blurry and treatments can serve both purposes. Why does this matter? Because the forced choice delays hospice enrollment. Patients and families resist hospice because accepting it feels like giving up. A national survey found that 78% of hospices had at least one enrollment policy restricting access for patients with potentially high-cost needs like chemotherapy or total parenteral nutrition. Chemotherapy drugs can cost nearly as much as the daily hospice per-diem rate, so hospices cannot absorb the cost. The result is that patients who could benefit from concurrent comfort care and disease-modifying treatment get neither optimally. The VA system has demonstrated a better model. A study of over 13,000 veterans found that concurrent hospice and cancer treatment led to less aggressive end-of-life care, fewer ICU admissions, and lower costs. CMS tested a Medicare Care Choices Model allowing concurrent care, but expanding it to all Medicare beneficiaries requires legislative change. The structural barrier is the 1982 statute's either-or design, built in an era when hospice was a philosophical alternative to hospital medicine rather than a complementary layer of care.